30 closest matches · ranked by relevance
Prescription Drug Insurance Decision Making
Primary: Count of Participants Whose 2017 Plan Differed From Their 2016 Plan — 85; 110; 86 Participants
Polypharmacy · Dementia · Multiple Chronic Conditions
Primary: Preliminary Efficacy of the Intervention to be Assessed From Primary Care Clinician's Intervention Visit Clinical Notes and EHR — 15; 7; 7; 7 Participants
Alzheimer Disease
Primary: Time to Dispensing of Inappropriate Medication Prescription — 76.7; 77.9; 77.5 Percentage of Cumulative Incidence — p=0.76
Aging · Benzodiazepine Sedative Adverse Reaction · Anticholinergic Adverse Reaction
Primary: Change in Inappropriate Prescribing by Study Arm: Descriptive Comparison Across Study Arms — 35.2; 33; 35.6; 40.6 percentage of patients
Aging · Benzodiazepine Sedative Adverse Reaction · Anticholinergic Adverse Reaction
Primary: Change in Inappropriate Prescribing — 106; 145; 122 Participants — p=0.002
Hyperlipidemia · Hypertension · Diabetes
Primary: Blood Pressure Medication Adherence — 396; 470 Participants — p=0.0103
Medication Abuse
Primary: Percentage of PDMP Checks Conducted During High-risk Prescriptions — 8187; 6322; 13360; 23328 health care encounters
Depression
Primary: Number of Participants Who Adhered to Physician Recommended Treatment — 40; 16 Participants
Health Literacy · Health Insurance · Health Services Accessibility
Primary: Knowledge Score (% Correct) — 77.6; 58.8 percentage of 8 items correctly answered — p=<.001
Machine Intelligence in the Pharmacy
Primary: Reaction Time — 3668; 4727; 4510 millisecond (ms)
Low Back Pain
Primary: Self-reported QOL - Physical Health — 41.7; 28.8; 31.8; 32.9 units on a scale
Economics · Fraud · Delivery of Health Care
Primary: 30-day Equivalent Prescribing of Schedule II Controlled Substances — 461.1; 450.0 30-day equivalent prescription fills
End Stage Renal Disease · Chronic Kidney Diseases
Primary: Mean Feasibility of Intervention Measure — 16.4; 16.1; 19.0 score on a scale
Opioid Use · Opioid-Related Disorders
Primary: Subacute Phase - More Than 7 Days of Opioids — 1.9; 12.2 % of participants — p=<.001
Bipolar Disorder
Primary: Inpatient Hospitalizations Among Bipolar Patients — 0.17; 0.17 hospitalizations per year
Pregnancy · Cesarean Section · Prescriptions
Primary: Pain Management and Opioid Usage Measured by Telephone Questionnaire — 20.0; 20.0; 15.5; 4.0 number of oxycodone 5mg tablets — p=<0.001
Depression · Opioid Use · Chronic Pain
Primary: Odds of Morphine Equivalent Daily Dose (MEDD) of Opioid Prescription >=50 mg — 0.209; 0.417; 0.185; 0.364 odds of prescription high dose — p=0.956
Opioid-use Disorder · Opioid Use · Opioid Abuse
Primary: Opioid Tapering Rate, Category 1 — 0.0193; 0.0359; 0.0268; 0.0192 proportion
Medical Overuse · Inappropriate Prescribing · Deprescriptions
Primary: Deprescribing — 748; 653 Participants — p=0.008
Opioid-use Disorder · Opioid Use · Opioid Abuse
Primary: Opioid Prescription Rate — 0.0159; 0.0141; 0.0161; 0.0120 percent
Prescription Drug Abuse · Substance Abuse · Substance Use (Drugs, Alcohol)
Primary: Prescription Drug Misuse (i.e., Prescription Drug Use Without a Doctor's Prescription) — 1.06; 1.12; 1.11; 1.13 score on a scale
Alzheimer Disease · Dementia Alzheimers · Dementia of Alzheimer Type
Primary: Cumulative Total of New Antipsychotic Pill-days Prescribed — 12569; 25916 New antipsychotic prescription days
Opioid-use Disorder · Opioid Use · Opioid Abuse
Primary: Frequency of PDMP Checks — 19; 23; 31.9; 22.1 PDMP queries per PCP per month
Health Literacy · Health Insurance · Health Services Accessibility
Primary: Knowledge — 6.0; 5.7; 5.5 Units on a scale
Major Depressive Disorder · Healthy Controls
Primary: Money Earned — 23.2; 25.0; 20.5; 21.9 US Dollars
Diabetes Mellitus
Primary: Percent of Participants Using Mail Order Pharmacy (MOP) After Intervention — 10.6; 9.3 percentage of participants — p=<0.001
Type II Diabetes
Primary: Patient Medication Preference as Estimated by a Choice Model — 0.983; 0.362; 0.284; 0.261 utility of
Feedback, Psychological · Clinical Trial · Substance Abuse
Primary: Change in Past 6 Month Non-Medical Use of Prescription Stimulant Medication Frequency — -2.04; -1.72; -1.03; -.38 Usage days — p=0.03
Type 2 Diabetes Treated With Insulin · Hypoglycemia · Primary Health Care
Primary: Clinical Outcome: Number of Participants With Glycemic Regimen De-prescribing — 34; 21 Participants
Colorectal Cancer
Primary: Number of Participants Reporting Preferred Screening Type as Reported by Chart Audits — 111; 99 participants